What the hip injection site usually tells you

A useful starting point is the pain map. The first split is usually between pain felt deep in the groin, pain on the outside of the hip, and pain at the front of the hip. Those three patterns often point to three different targets, and the target changes whether the injection is being used mainly for short-term treatment, diagnosis, or a mix of both.

• Intra-articular hip joint injection: this places steroid inside the hip joint. It is more often considered when arthritis or another intra-articular problem is suspected, and the story is often deep groin pain, stiffness, and painful rotation rather than tenderness over the skin.
• Trochanteric bursa / GTPS injection: this is aimed at the outer hip around the greater trochanter. It more often fits pain on the outside of the hip, sometimes worse when lying on that side or with uphill walking. The evidence suggests steroid may help some people in the short to medium term, although it may not outperform exercise-based care.
• Iliopsoas bursa injection: this targets the front of the hip. It is used when anterior hip pain, painful snapping, or some pain after hip replacement suggests the iliopsoas region, and it can be diagnostic as well as therapeutic.

That is why the label on the request form matters less than the suspected pain generator. These are not interchangeable injections: each one is trying to answer a different clinical question.

When the hip joint is the target

Deep groin pain is the pattern that most often keeps the hip joint itself in view. When symptoms seem to arise from the acetabulofemoral joint, they often behave like joint pain rather than surface tenderness: start-up stiffness after rest, reduced hip rotation, and pain with weight-bearing or twisting are common clues. In that setting, an intra-articular cortisone injection is aimed at pathology within the joint, most often hip osteoarthritis, rather than a problem in the outer or front soft tissues.

In practice, these injections are commonly performed with imaging guidance. The hip is a deep ball-and-socket joint, and published studies of hip corticosteroid injection typically describe guided placement, which matters because the result is only meaningful if the medicine actually reaches the joint. If the usual pain settles after a guided injection, that can support the hip joint as the main pain source and give the injection a diagnostic role as well as a therapeutic one.

Expectations still need to stay modest. In a 2024 arthroplasty-clinic cohort, mean pain relief after intra-articular hip steroid injection for osteoarthritis was 6.7 weeks, and the authors found no clinically meaningful delay to hip replacement for most patients.

When the outer hip bursa is the target

By contrast, pain centred on the outside of the hip usually points away from the hip joint itself and towards the greater trochanter region. A steroid injection here is typically aimed at the trochanteric bursa or the broader picture called greater trochanteric pain syndrome (GTPS), not at arthritis inside the ball-and-socket joint. Common clues are marked tenderness over that outer bony point, pain when lying on the affected side at night, and irritation with walking or stairs.

That distinction matters because lateral hip pain often behaves more like a soft-tissue problem around the greater trochanter than a worn hip joint. In practical terms, the injection may settle pain and local inflammation, but it does not by itself rebuild hip strength, improve movement control, or change the loading pattern that may have stirred the symptoms up in the first place.

The evidence is useful but not sweeping. A systematic review of 8 randomised trials involving 764 patients found that corticosteroid injection for GTPS may improve pain or function compared with usual care or a “wait and see” approach in the short to medium term. However, the overall picture was mixed, and injection did not consistently outperform exercise, PRP, dry needling, or sham treatment; some longer-term results were inferior to PRP or ESWT. So when the outer hip bursa is the target, the shot is usually a short-term pain-settling option within a rehab plan, not a substitute for it.

When the front of the hip is the target

Anterior groin pain raises a different question: is the source inside the hip joint, or in front of it where the iliopsoas tendon and bursa sit? When pain is clearly felt at the front of the hip, or comes with a painful snapping hip pattern, an iliopsoas bursa injection may be a better match than an injection placed inside the joint. The same target is also used in some cases of persistent groin pain after hip replacement, when iliopsoas irritation is suspected.

This injection can serve two purposes. It may settle pain, but it can also be diagnostic: if the familiar front-of-hip pain eases after a guided injection, that supports the iliopsoas region as an important pain source. That matters because pain at the front of the hip is not automatically pain from the hip joint itself, and more than one structure can contribute around the same area.

The evidence is supportive, but smaller and less mature than the literature often discussed for intra-articular hip joint injections. In a 2024 cohort of 68 patients with iliopsoas tendinopathy, bursitis or snapping hip, ultrasound-guided corticosteroid injection was associated with significant improvement at 3 and 6 months. That front-versus-inside distinction is a key part of choosing the right target.

How often can a hip cortisone injection be repeated

The short answer is that there is no fixed timetable for repeating a hip cortisone injection, and any repeat decision has to be weighed against how much benefit the last injection gave and what the next stage in the hip pathway may be.

Extra caution applies when the injection is placed inside the hip joint itself. In a 2024 arthroplasty-clinic cohort, mean pain relief after intra-articular corticosteroid injection for hip osteoarthritis was 6.7 weeks, which shows how quickly some patients can end up in a repeat-injection cycle with only brief benefit. Reviews published in 2023 and 2025 also reported structural concerns after intra-articular hip steroid injection, including rapidly progressive osteoarthritis, but the true risk remains uncertain because study definitions and follow-up varied.

Timing matters even more if hip replacement may be on the horizon. A meta-analysis found higher periprosthetic joint infection risk when an intra-articular hip injection was given before total hip arthroplasty, with the clearest concern inside the 3 months before surgery. So the practical question is not only whether the injection can be repeated, but what the next step is if relief is brief, incomplete, or keeps wearing off.

When to book a hip assessment

Assessment earns its value when the pattern changes: pain returns within weeks, stiffness worsens, night pain appears, or hip surgery is entering the picture within 3 months. At that stage, the useful question is not booking logistics or the brand of steroid, but whether the pain source has been identified correctly in the hip joint, the greater trochanter region, or the iliopsoas area.

When the picture is mixed, a guided injection may be used as a "diagnostic" step as well as treatment. Temporary easing after an intra-articular injection supports the hip joint as a major driver; change after an iliopsoas bursa injection supports the front-of-hip pain generator. Lateral hip pain remains more consistent with the greater trochanter region than with pain arising from inside the hip joint.

A short-lived response can be a clue in itself: in one 2024 hip osteoarthritis cohort, mean relief after intra-articular steroid was 6.7 weeks, and injections given within 3 months of hip replacement have been linked with higher infection risk. For Lincolnshire Hip, the practical takeaway is compact: groin-dominant pain keeps the joint in view, the outer hip points lateral, snapping at the front points iliopsoas, and the right injection is the one matched to the structure actually causing the pain today.

1. [1] Clinical Efficacy of Ultrasound-guided Iliopsoas Corticosteriod Injection for Hip Pain. (2024). https://doi.org/10.17161/kjm.vol17.22757 https://doi.org/10.17161/kjm.vol17.22757